Paediatric Dermatology Limited - Accounts to registrar (filleted) - small 18.2

Paediatric Dermatology Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v22.1.4.3 09103796 director 1.4.21 31.3.22 31.3.22 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure091037962021-03-31091037962022-03-31091037962021-04-012022-03-31091037962020-03-31091037962020-04-012021-03-31091037962021-03-3109103796ns16:EnglandWales2021-04-012022-03-3109103796ns15:PoundSterling2021-04-012022-03-3109103796ns11:Director12021-04-012022-03-3109103796ns11:PrivateLimitedCompanyLtd2021-04-012022-03-3109103796ns11:SmallEntities2021-04-012022-03-3109103796ns11:AuditExempt-NoAccountantsReport2021-04-012022-03-3109103796ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-3109103796ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-3109103796ns11:FullAccounts2021-04-012022-03-3109103796ns11:RegisteredOffice2021-04-012022-03-3109103796ns6:CurrentFinancialInstruments2022-03-3109103796ns6:CurrentFinancialInstruments2021-03-3109103796ns6:ShareCapital2022-03-3109103796ns6:ShareCapital2021-03-3109103796ns6:FurtherSpecificReserve3ComponentTotalEquity2022-03-3109103796ns6:FurtherSpecificReserve3ComponentTotalEquity2021-03-3109103796ns6:RetainedEarningsAccumulatedLosses2022-03-3109103796ns6:RetainedEarningsAccumulatedLosses2021-03-3109103796ns6:AdditionsToInvestments2022-03-3109103796ns6:RevaluationsIncreaseDecreaseInInvestments2022-03-3109103796ns6:CostValuation2022-03-3109103796ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3109103796ns6:WithinOneYearns6:CurrentFinancialInstruments2021-03-31
REGISTERED NUMBER: 09103796 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 March 2022

for

Paediatric Dermatology Limited

Paediatric Dermatology Limited (Registered number: 09103796)






Contents of the Financial Statements
for the Year Ended 31 March 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Paediatric Dermatology Limited

Company Information
for the Year Ended 31 March 2022







DIRECTOR: Dr A E Martinez





REGISTERED OFFICE: 40 Kings Road
St Albans
Hertfordshire
AL3 4TG





REGISTERED NUMBER: 09103796 (England and Wales)





ACCOUNTANTS: Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP

Paediatric Dermatology Limited (Registered number: 09103796)

Balance Sheet
31 March 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Investments 4 474,136 -

CURRENT ASSETS
Debtors 5 24,592 32,650
Cash at bank 78,459 478,239
103,051 510,889
CREDITORS
Amounts falling due within one
year

6

48,835

37,799
NET CURRENT ASSETS 54,216 473,090
TOTAL ASSETS LESS CURRENT
LIABILITIES

528,352

473,090

CAPITAL AND RESERVES
Called up share capital 1 1
Fair value reserve 7 10,208 -
Retained earnings 518,143 473,089
528,352 473,090

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Paediatric Dermatology Limited (Registered number: 09103796)

Balance Sheet - continued
31 March 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 July 2022 and were signed by:





Dr A E Martinez - Director


Paediatric Dermatology Limited (Registered number: 09103796)

Notes to the Financial Statements
for the Year Ended 31 March 2022

1. STATUTORY INFORMATION

Paediatric Dermatology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents trading income accrued during the period shown by these financial statements.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 3 ) .

Paediatric Dermatology Limited (Registered number: 09103796)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2022

4. FIXED ASSET INVESTMENTS
Other
investmen
£   
COST OR VALUATION
Additions 487,500
Revaluations (14,419 )
Dividends received 1,055
At 31 March 2022 474,136
NET BOOK VALUE
At 31 March 2022 474,136

Cost or valuation at 31 March 2022 is represented by:

Other
investmen
£   
Valuation in 2022 474,136

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade debtors 24,592 30,296
Other debtors - 2,354
24,592 32,650

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Taxation and social security 44,919 34,781
Other creditors 3,916 3,018
48,835 37,799

Paediatric Dermatology Limited (Registered number: 09103796)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2022

7. RESERVES
Fair
value
reserve
£   
No description 10,208

At 31 March 2022 10,208